skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website
Publication Briefs

National Campaign Reduces Prostate Cancer Imaging in Sweden


BACKGROUND:
Recently, the American Society of Clinical Oncology and the American Urological Association highlighted the need to reduce inappropriate imaging for low-risk prostate cancer in the Choosing Wisely campaign, a multi-disciplinary effort to reduce unnecessary medical testing, decrease overuse of healthcare resources, and improve quality of care. Since 2000, the National Prostate Cancer Register (NPCR) of Sweden also has engaged in an effort to reduce inappropriate diagnostic imaging. The NPCR collected data to generate local, hospital-level reports of the frequency of imaging use for patients with low-risk prostate cancer. These data, along with imaging guidelines from professional societies in Europe, the US, and Sweden, as well as important literature, are presented annually to Swedish urologists attending regional and national urology meetings, accompanied by the message that reducing inappropriate imaging is important. This retrospective cohort study assessed NPCR's effort to reduce inappropriate prostate cancer imaging by examining imaging trends over time across Sweden, taking into consideration clinical risk category (low, intermediate, high), geographic region, as well as patients' age and comorbidity. Analyses included 99,879 men diagnosed with prostate cancer from 1998-2009.

FINDINGS:

  • Overall, prostate cancer imaging decreased over time, particularly for men in the low-risk (inappropriate imaging) category, among whom the imaging rate decreased from 45% to 3%, but also for men in the high-risk (appropriate imaging) category, among whom the rate decreased from 63% to 47%.
  • Despite substantial regional variation, all regions in Sweden experienced significant decreases in prostate cancer imaging.

LIMITATIONS:

  • It is not possible to demonstrate that the NPCR intervention, and not secular trends, was responsible for the decrease in inappropriate imaging.
  • Differences across healthcare systems might reduce the generalizability of the approach described here for countries that do not have a uniform national healthcare system.

IMPLICATIONS:

  • Many previous guidelines and policy efforts have failed to reduce inappropriate prostate cancer imaging in the U.S. These results may inform current efforts to promote guideline concordant imaging, especially in a coordinated healthcare system such as VA.
  • Efforts to curb inappropriate imaging may best be coupled with efforts to encourage appropriate imaging, so that improving care for low-risk patients is not at the expense of high-risk patients.

AUTHOR/FUNDING INFORMATION:
Dr. Makarov is supported by an HSR&D Career Development Award and is part of the VA New York Harbor Healthcare System.


PubMed Logo Makarov D, Loeb S, Ulmert D, et al. Prostate Cancer Imaging Trends Following a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging. Journal of the National Cancer Institute September 4, 2013;105(17):1306-13.

Related Briefs

» next 63 Cancer Briefs...


What are HSR Publication Briefs?

HSR requires notification by HSR-funded investigators about all articles accepted for publication. These journal articles are reviewed by HSR and publication briefs or summaries are written for a select number of articles that are then forwarded to VHA Central Office leadership to keep them informed about important findings or information. Articles to be summarized are selected by HSR based on timeliness of the findings, interest of leadership, or potential impact on the organization. Publication briefs are written for only a small number of HSR published articles. Visit the HSR citations database for a complete listing of HSR articles and presentations.


Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.